Rendering

Component: (Network and Table)
Network
100260 - Disclosure - Intangible Assets and Goodwill (Tables)
(http://www.acorda.com/20161231/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Goodwill And Intangible Assets Disclosure [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Goodwill And Intangible Assets Disclosure [Abstract]
 
Schedule of Intangible Assets

 

 

 

 

 

 

December 31, 2016

 

 

December 31, 2015

 

(Dollars In thousands)

 

Estimated

Remaining

Useful Lives

(Years)

 

 

Cost

 

 

Accumulated

Amortization

 

 

Foreign

Currency

Translation

 

 

Net

Carrying

Amount

 

 

Cost

 

 

Accumulated

Amortization

 

 

Net

Carrying

Amount

 

In-process research &

   development (1)

 

Indefinite-lived

 

 

$

683,500

 

 

$

 

 

$

(1,794

)

 

$

681,706

 

 

$

423,000

 

 

$

 

 

$

423,000

 

Selincro

 

 

6

 

 

 

65,000

 

 

 

(6,445

)

 

 

(4,061

)

 

 

54,494

 

 

 

 

 

 

 

 

 

 

Ampyra milestones

 

 

10

 

 

 

5,750

 

 

 

(2,677

)

 

 

 

 

 

3,073

 

 

 

5,750

 

 

 

(2,380

)

 

 

3,370

 

Ampyra CSRO royalty

   buyout

 

 

3

 

 

 

3,000

 

 

 

(2,108

)

 

 

 

 

 

892

 

 

 

3,000

 

 

 

(1,817

)

 

 

1,183

 

Website development

   costs

 

 

3

 

 

 

13,459

 

 

 

(11,485

)

 

 

 

 

 

1,974

 

 

 

12,504

 

 

 

(9,467

)

 

 

3,037

 

Website development

   costs–in process

 

n/a

 

 

 

103

 

 

 

 

 

 

 

 

 

103

 

 

 

266

 

 

 

 

 

 

266

 

 

 

 

 

 

 

$

770,812

 

 

$

(22,715

)

 

$

(5,855

)

 

$

742,242

 

 

$

444,520

 

 

$

(13,664

)

 

$

430,856

 

 

(1)

Includes the fair values of:  CVT-301: $423.0 million; tozadenant: $232.0 million; SYN120: $24.2 million and BTT-1023: $4.3 million

 
 
Schedule of Estimated Future Amortization Expense for Intangible Assets

 

(In thousands)

 

 

 

 

2017

 

$

11,119

 

2018

 

 

10,423

 

2019

 

 

10,055

 

2020

 

 

9,602

 

2021

 

 

9,583

 

Thereafter

 

 

13,712

 

 

 

$

64,494

 

 

 
 
Schedule of Changes in Carrying Amount of Goodwill

 

(In thousands)

 

 

 

 

Balance at December 31, 2015

 

$

183,636

 

Goodwill associated with the acquisition of Biotie Therapies Corp.

 

 

102,676

 

Increase to goodwill due to measurement period adjustments

 

 

1,200

 

Foreign currency translation adjustment

 

 

(6,913

)

Balance at December 31, 2016

 

$

280,599